- Title
- Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment
- Creators
- Jonathan I Silverberg - George Washington UniversityAndreas Wollenberg - University Hospital AugsburgLinda Stein Gold - Henry Ford Health SystemJames Del Rosso - JDR Dermatology Research, Las Vegas, NV, USAGil Yosipovitch - University of MiamiPeter Lio - Northwestern UniversityJose-Manuel Carrascosa - Hospital Universitari Germans Trias i PujolGaia Gallo - Eli LillyYuxin Ding - Eli LillyZhenhui Xu - Product Innovation and Engineering (United States, Saint James) - LLCMarta Casillas - Eli LillyEvangeline Pierce - Eli LillyHelena Agell - AlmirallSonja Ständer - University Hospital Münster
- Publication Details
- Dermatology and therapy
- Academic Unit
- Miller School of Medicine; UMMG Dept of Dermatology & Cutaneous Surgery
- Language
- English
- Resource Type
- Journal article
- PMID
- 39424713
- Record Identifier
- 991032431436002976
Journal article
Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment
Dermatology and therapy
2024-10-18
PMID: 39424713
Metrics
1 Record Views